This tutorial presents the workflow of adapting an adult physiologically based pharmacokinetic (PBPK) model to the pregnant populations using the Open Systems Pharmacology (OSP) software suite (www.open-systems-pharmacology.org). This workflow is illustrated using a previously published PBPK model for metronidazole that is extrapolated to pregnancy by parameterizing and extending the model structure in terms of pregnancy‐induced physiological changes. Importantly, this workflow can be applied to other scenarios where PBPK models need to be re‐parameterized or structurally modified
Many parameters treated as constants in traditional physiologically based pharmacokinetic models mus...
International audiencePharmacokinetics study the fate of xenobiotics in a living organism. Physiolog...
A PBPK model for lead kinetics in the human body, female, from birth to end of first pregnancy. Writ...
The unmet medical need of providing evidence-based pharmacotherapy for pregnant women is recognized ...
Changes in maternal physiology and metabolic during pregnancy influence pharmacokinetics and illustr...
Physiologically based pharmacokinetics (PBPK) modelling is widely used in medicine development and r...
Background: Pregnancy is associated with considerable changes in the physiological, anatomical and b...
BACKGROUND: In clinical pharmacokinetic (PK) studies, pregnant women are significantly underrepresen...
Personalized medicine aims to determine the most adequate treatment and dose regimen to obtain the m...
Physiologically Based Pharmacokinetic (PBPK) models are mechanistic tools generally employed in the ...
Aims Physiologically based pharmacokinetic (PBPK) models have been previously developed for betamet...
Thesis (Ph.D.)--University of Washington, 2013Physiological and ADME changes during pregnancy can si...
AbstractPhysiologically based pharmacokinetic (PBPK) modeling and simulation can be used to predict ...
Physiologically Based Pharmacokinetic (PBPK) models are mechanistic tools generally employed in the ...
Introduction: Legal initiatives to stimulate neonatal drug development should be accompanied by deve...
Many parameters treated as constants in traditional physiologically based pharmacokinetic models mus...
International audiencePharmacokinetics study the fate of xenobiotics in a living organism. Physiolog...
A PBPK model for lead kinetics in the human body, female, from birth to end of first pregnancy. Writ...
The unmet medical need of providing evidence-based pharmacotherapy for pregnant women is recognized ...
Changes in maternal physiology and metabolic during pregnancy influence pharmacokinetics and illustr...
Physiologically based pharmacokinetics (PBPK) modelling is widely used in medicine development and r...
Background: Pregnancy is associated with considerable changes in the physiological, anatomical and b...
BACKGROUND: In clinical pharmacokinetic (PK) studies, pregnant women are significantly underrepresen...
Personalized medicine aims to determine the most adequate treatment and dose regimen to obtain the m...
Physiologically Based Pharmacokinetic (PBPK) models are mechanistic tools generally employed in the ...
Aims Physiologically based pharmacokinetic (PBPK) models have been previously developed for betamet...
Thesis (Ph.D.)--University of Washington, 2013Physiological and ADME changes during pregnancy can si...
AbstractPhysiologically based pharmacokinetic (PBPK) modeling and simulation can be used to predict ...
Physiologically Based Pharmacokinetic (PBPK) models are mechanistic tools generally employed in the ...
Introduction: Legal initiatives to stimulate neonatal drug development should be accompanied by deve...
Many parameters treated as constants in traditional physiologically based pharmacokinetic models mus...
International audiencePharmacokinetics study the fate of xenobiotics in a living organism. Physiolog...
A PBPK model for lead kinetics in the human body, female, from birth to end of first pregnancy. Writ...